Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.

Brain : a journal of neurology - 1 Dec 1996

Antonini A, Leenders K L, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, Sanchez-Pernaute R, de Yébenez J G, Boesiger P, Weindl A, Maguire R P

Abstract excerpt

We used PET scans with the tracers [18F]fluorodeoxyglucose (FDG) and [11C]raclopride (RACLO) to study glucose metabolism and dopamine D2 receptor binding in the caudate nucleus and putamen of 18 carriers of the Huntington's disease gene mutation (10 asymptomatic subjects and eight untreated sympt...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbon Radioisotopes
Share to Deoxyglucose
Share to BCR gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucose

Share to Heterozygote

Share to Huntington Disease

Share to Mutation

Share to Receptors, Dopamine D2

Source

Identifiers

PMID: 9010012
DOI: 10.1093/brain/119.6.2085

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-9010012-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.PMID 9010012Read ↗

Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's diseaseSemantic proximity Read ↗

Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease.Semantic proximity Read ↗

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease.Semantic proximity Read ↗

DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease.Semantic proximity Read ↗

Molecular Imaging Markers to Track Huntington’s Disease PathologySemantic proximity Read ↗

Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease.Semantic proximity Read ↗

Serial DaT-SPECT imaging in asymptomatic carriers of LRRK2 G2019S mutation: 8 years' follow-up.Semantic proximity Read ↗

Benzodiazepine receptor binding in Huntington's disease: [11C]Flumazenil uptake measured using positron emission tomographySemantic proximity Read ↗

Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year.Semantic proximity Read ↗

Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.Semantic proximity Read ↗

A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.Semantic proximity Read ↗

Hypothalamic involvement in Huntington's disease: an in vivo PET studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.